Busch Jeffrey 4

Accession 0001493152-24-004817

CIK 0001362703other

View on SEC.gov Company Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:10 PM ET

Size

19.1 KB

Accession

0001493152-24-004817

Insider Transaction Report

Form 4

Period: 2022-11-29

THERALINK TECHNOLOGIES, INC.THER

Busch Jeffrey

Director

Transactions

Other
10% O.I.D. Senior Secured Convertible Debenture
2022-11-29
Exercise: $0.00From: 2023-11-29Exp: 2023-11-29→ Common Stock (103,161,667 underlying)
Award
10% O.I.D. Senior Secured Convertible Debenture
2022-11-29$50000.00/sh
Exercise: $0.00From: 2023-11-29Exp: 2023-11-29→ Common Stock (18,333,333 underlying)
Other
Common Stock Purchase Warrant
2022-11-29+88,424,286→ 88,424,286 total
Exercise: $0.00From: 2023-11-29Exp: 2029-05-29→ Common Stock (88,424,286 underlying)
Award
10% O.I.D. Senior Secured Convertible Debenture
2023-04-22$141000.00/sh
Exercise: $0.00From: 2023-11-29Exp: 2023-11-29→ Common Stock (51,700,000 underlying)
Award
Common Stock Purchase Warrant
2022-11-29+15,714,286→ 15,714,286 total
Exercise: $0.00From: 2023-11-29Exp: 2029-05-29→ Common Stock (15,714,286 underlying)
Award
Common Stock Purchase Warrant
2023-04-22+44,314,286→ 44,314,286 total
Exercise: $0.00From: 2023-11-29Exp: 2029-05-29→ Common Stock (44,314,286 underlying)

Footnotes (7)

[F1]Assumes a fixed conversion price of $0.003, but such conversion price is subject to adjustment as set forth in the debenture and warrant, respectively.
[F2]The Reporting Person was issued a 10% Original Issue Discount ("O.I.D.") Senior Secured Convertible Debenture in the principal amount of $309,485 and 88,424,286 warrants in exchange for a demand promissory note in the principal amount of $250,000 previously issued to the Reporting Person.
[F3]The debentures and warrants acquired by the Reporting Person are subject to mandatory conversion upon the occurrence of certain events, as outlined in the debentures and warrants. The original maturity date of the debentures was subsequently extended to February 29, 2024.
[F4]Excludes shares issuable at the election of the Reporting Person upon conversion of accrued interest (both past and future) into shares of common stock.
[F5]Expiration Date in the event a Qualified Offering is not consummated prior to the maturity date of the debentures the Warrants are issued in connection with.
[F6]The Reporting Person purchased a 10% O.I.D. Senior Secured Convertible Debenture in the principal amount of $55,000 and 15,714,286 Warrants for an aggregate purchase price of $50,000 in a private placement offering that closed on November 29, 2022.
[F7]The Reporting Person purchased a 10% O.I.D. Senior Secured Convertible Debenture in the principal amount of $155,100 and 44,314,286 Warrants for an aggregate purchase price of $141,000 in a private placement offering that closed on April 22, 2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

THERALINK TECHNOLOGIES, INC.

CIK 0001362703

→

Entity typeother

Related Parties

filerCIK 0001620772

Filing Metadata

Form type: 4
Filed: Feb 1, 7:00 PM ET
Accepted: Feb 2, 8:10 PM ET
Size: 19.1 KB

View on SEC.gov